Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2019-03-12 Report Publication Anno…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Datum:12.03.2019
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 800 characters) titled 'Hinweis auf Jahresfinanzbericht' (Notice of Annual Financial Report). It provides the publication date and a URL link to the actual report rather than containing the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2019-03-12 German
STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer
Capital/Financing Update Classification · 99% confidence The document is titled "Announcement of the Results of the Tender Offer" by STADA Arzneimittel Aktiengesellschaft. It details the outcome of an offer to purchase outstanding Notes (bonds), including the principal amount tendered, acceptance decision, and payment dates. This activity directly relates to changes in the company's capital structure or financing instruments, specifically debt repurchase. This aligns best with the 'Capital/Financing Update' category (CAP), as it reports the conclusion of a tender offer for outstanding debt securities.
2019-02-21 English
STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer
Capital/Financing Update Classification · 99% confidence The document is titled "Announcement of the Results of the Tender Offer" by STADA Arzneimittel AG regarding its offer to purchase outstanding 1.750% Notes due 2022. It details the results of the tender offer, including the amount tendered and the expected payment date. This activity—a company offering to buy back its own debt securities (Notes)—falls under corporate financing and capital structure changes. While it relates to debt, the core action is a transaction involving securities repurchase/exchange, which aligns most closely with 'Transaction in Own Shares' (POS) if interpreted broadly to include debt buybacks, or 'Capital/Financing Update' (CAP). Given the specific nature of announcing the results of a tender offer for existing debt, 'Capital/Financing Update' (CAP) is a strong fit as it covers financing activities. However, the action is fundamentally a transaction involving the company's securities (Notes). Since there is no specific code for 'Debt Tender Offer Result', and the action is a direct transaction involving the company's capital structure/securities, 'CAP' (Capital/Financing Update) is the most appropriate category covering this type of corporate finance event, as it is not a standard equity repurchase (POS). It is a formal announcement of a financing event outcome, not a general regulatory filing (RNS) or a management report (MDA).
2019-01-22 English
STADA Arzneimittel Aktiengesellschaft offer to purchase for cash any and all of its outstanding 1.750% Notes due 2022
Capital/Financing Update Classification · 98% confidence The document is an announcement dated January 8, 2019, from STADA Arzneimittel Aktiengesellschaft regarding an 'offer to purchase for cash any and all of its outstanding 1.750% Notes due 2022'. It explicitly mentions a 'Tender Offer Memorandum' and details the terms, expiration dates, and procedures for tendering bonds. This activity—a formal offer to buy back outstanding debt securities—falls under financing or capital structure activities. Reviewing the definitions, 'Capital/Financing Update (Code: CAP)' is the most appropriate category as it covers 'Updates on company fundraising, financing activities, or capital structure changes.' While it relates to debt, it is not a general regulatory filing (RNS) or a specific legal proceeding (LTR), but a direct action concerning the company's capital structure (debt retirement).
2019-01-08 English
STADA's EUR 300,000,000 1.75% Senior Notes due 2022
Capital/Financing Update Classification · 99% confidence The document is a short news release dated December 20, 2018, announcing actions related to STADA's EUR 300,000,000 Senior Notes due 2022. Specifically, it details the granting of security and the intention to launch a Tender Offer to repurchase these notes. This action directly relates to the company's debt structure and financing activities. Based on the definitions, this falls under 'Capital/Financing Update' (CAP), as it concerns debt instruments and potential repurchase offers, which are core financing activities. It is too specific for a general 'Regulatory Filing' (RNS) and is not a full report (10-K, IR) or an earnings release (ER).
2018-12-20 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in voting rights percentages for a specific shareholder (Paul E. Singer) in STADA Arzneimittel AG, crossing or reaching a threshold on 28 Nov 2018. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2018-12-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.